Rare diseases
Investigational molecules
Locations
Back to Italy2 907 clinical trials in Legnano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Zetomipzomib for Patients with Active Lupus Nephritis
ItalyStudy of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
ItalyStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
ItalyStudy on the Effectiveness and Safety of Iptacopan for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) Switching from Anti-C5 Antibody Treatment
ItalyStudy Comparing ARV-471 and Palbociclib with Letrozole and Palbociclib for Patients with Estrogen Receptor Positive, HER2-Negative Advanced Breast Cancer
ItalyStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
ItalyStudy on the Effects of Siplizumab in Adults with New Onset Type 1 Diabetes
ItalyStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
ItalyStudy on the Safety and Effects of SAR442501 for Children with Achondroplasia
ItalyStudy Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma
ItalyStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
ItalyStudy on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Myeloma treatments, including innovative therapies for relapsed and refractory cases. Studies evaluating new drug combinations and treatment approaches for better patient outcomes.
Multiple ongoing trials testing various therapeutic combinations to improve survival rates.
Groundbreaking studies in lung cancer and breast cancer treatment, investigating novel immunotherapy combinations and targeted therapies.
Focus on personalized treatment approaches and biomarker-driven therapies.
Innovative research in chronic kidney disease and HIV management, exploring new treatment strategies and medication combinations.
Studies aimed at improving long-term patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
